| Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 J Huo, A Le Bas, RR Ruza, HME Duyvesteyn, H Mikolajek, T Malinauskas, ... Nature structural & molecular biology 27 (9), 846-854, 2020 | 469 | 2020 |
| The antigenic anatomy of SARS-CoV-2 receptor binding domain W Dejnirattisai, D Zhou, HM Ginn, HME Duyvesteyn, P Supasa, JB Case, ... Cell 184 (8), 2183-2200. e22, 2021 | 353 | 2021 |
| Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient D Zhou, HME Duyvesteyn, CP Chen, CG Huang, TH Chen, SR Shih, ... Nature structural & molecular biology 27 (10), 950-958, 2020 | 286 | 2020 |
| Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine RP Payne, S Longet, JA Austin, DT Skelly, W Dejnirattisai, S Adele, ... Cell 184 (23), 5699-5714. e11, 2021 | 267 | 2021 |
| The structure of the influenza A virus genome B Dadonaite, B Gilbertson, ML Knight, S Trifkovic, S Rockman, ... Nature microbiology 4 (11), 1781-1789, 2019 | 202 | 2019 |
| SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus MI Andersson, CV Arancibia-Carcamo, K Auckland, JK Baillie, E Barnes, ... Wellcome open research 5, 2020 | 171 | 2020 |
| Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern DT Skelly, AC Harding, J Gilbert-Jaramillo, ML Knight, S Longet, A Brown, ... Nature communications 12 (1), 5061, 2021 | 155 | 2021 |
| T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study A Angyal, S Longet, SC Moore, RP Payne, A Harding, T Tipton, ... The Lancet Microbe 3 (1), e21-e31, 2022 | 129 | 2022 |
| Correlative multi-scale cryo-imaging unveils SARS-CoV-2 assembly and egress L Mendonça, A Howe, JB Gilchrist, Y Sheng, D Sun, ML Knight, ... Nature Communications 12 (1), 4629, 2021 | 122 | 2021 |
| Global analysis of protein-RNA interactions in SARS-CoV-2-infected cells reveals key regulators of infection W Kamel, M Noerenberg, B Cerikan, H Chen, AI Järvelin, M Kammoun, ... Molecular Cell 81 (13), 2851-2867. e7, 2021 | 122 | 2021 |
| Breadth and function of antibody response to acute SARS-CoV-2 infection in humans KYA Huang, TK Tan, TH Chen, CG Huang, R Harvey, S Hussain, ... Plos pathogens 17 (2), e1009352, 2021 | 70 | 2021 |
| The SARS-CoV-2 RNA polymerase is a viral RNA capping enzyme AP Walker, H Fan, JR Keown, ML Knight, JM Grimes, E Fodor Nucleic acids research 49 (22), 13019-13030, 2021 | 40 | 2021 |
| Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity L Chauveau, A Bridgeman, TK Tan, R Beveridge, JN Frost, P Rijal, ... EMBO reports 22 (8), e52447, 2021 | 26 | 2021 |
| A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy X Miao, Y Luo, X Huang, SMY Lee, Z Yuan, Y Tang, L Chen, C Wang, ... MAbs 12 (1), 1804241, 2020 | 25 | 2020 |
| Comparative Molecular Biology Approaches for the Production of Poliovirus Virus-Like Particles Using Pichia pastoris L Sherry, K Grehan, JS Snowden, ML Knight, OO Adeyemi, DJ Rowlands, ... Msphere 5 (2), 10.1128/msphere. 00838-19, 2020 | 17 | 2020 |
| Structure of an H3N2 influenza virus nucleoprotein ML Knight, H Fan, DLV Bauer, JM Grimes, E Fodor, JR Keown Acta Crystallographica Section F: Structural Biology Communications 77 (7 …, 2021 | 14 | 2021 |
| Rotavirus RNA chaperone mediates global transcriptome-wide increase in RNA backbone flexibility A Coria, A Wienecke, ML Knight, D Desirò, A Laederach, A Borodavka Nucleic Acids Research 50 (17), 10078-10092, 2022 | 5 | 2022 |
| Genome structure in RNA viruses M Knight University of Oxford, 2021 | | 2021 |
